Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin. biomed. res ; 38(3): 308-310, 2018.
Article in English | LILACS | ID: biblio-1047051

ABSTRACT

Report of Chromobacterium violaceum isolation from blood culture. Identification by MALDI-TOF mass spectrometry. Relevant report due to the site affected, infection severity, and importance of correct and rapid identification for a successful treatment and lower risk of morbidity and mortality. (AU)


Subject(s)
Humans , Male , Middle Aged , Chromobacterium/pathogenicity , Sepsis/diagnosis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Blood Culture/methods
2.
J. bras. patol. med. lab ; 50(4): 278-279, Jul-Aug/2014. graf
Article in English | LILACS | ID: lil-723978

ABSTRACT

Chromobacterium violaceum is a rare pathogen that can potentially cause fatal infections in humans. An 8-year-old child from Natal, northeast of Brazil, presented history of fever, sore throat, and abdominal pain, during 5 days before admission, and died 4 hours after hospitalization. Chromobacterium violaceum was isolated from oropharynx scrapings and was resistant to ampicillin, cefotaxime, cefalotin, ceftazidime, and ceftriaxone...


Chromobacterium violaceum é um patógeno raro que potencialmente pode causar infecções fatais em humanos. Relatamos o caso de uma criança de 8 anos de idade, moradora da cidade de Natal, nordeste do Brasil, que apresentou história de febre, dor na garganta e no abdome durante os cinco dias anteriores à internação, e veio a falecer após 4 horas de hospitalização. A bactéria Chromobacterium violaceum foi isolada da orofaringe e apresentou resistência a ampicilina, cefotaxima, cefalotina, ceftazidima e ceftriaxona...


Subject(s)
Humans , Female , Child , Ampicillin Resistance , Chromobacterium/pathogenicity , Drug Resistance, Bacterial , Cefotaxime , Ceftriaxone , Cephalothin , Fatal Outcome
3.
Genet. mol. biol ; 32(3): 640-644, 2009. ilus, tab
Article in English | LILACS | ID: lil-522336

ABSTRACT

Groups of genes that produce exopolysaccharide with a N-acetyl-D-glucosamine monomer are in the genome of several pathogenic bacteria. Chromobacterium violaceum, an opportunistic pathogen, has the operon hmsHFR-CV2940, whose proteins can synthesize such polysaccharide. In this work, multiple alignments among proteins from bacteria that synthesize such polysaccharide were used to verify the existence of amino acids that might be critical for pathogen activity. Three-dimensional models were generated for spatial visualization of these amino acid residues. The analysis carried out showed that the protein HmsR preserves the amino acids D135, D228, Q264 and R267, considered critical for the formation of biofilms and, furthermore, that these amino acids are close to each other. The protein HmsF of C. violaceum preserves the residues D86, D87, H156 and W115. It was also shown that these residues are also close to each other in their spatial arrangement. For the proteins HmsH and CV2940 there is evidence of conservation of the residues R104 and W94, respectively. Conservation and favorable spatial location of those critical amino acids that constitute the proteins of the operon indicates that they preserve the same enzymatic function in biofilm synthesis. This is an indicator that the operon hmsHFR-CV2940 is a possible target in C. violaceum pathogenicity.


Subject(s)
Animals , Biofilms/growth & development , Chromobacterium/pathogenicity , Acetylglucosaminidase , Computational Biology , Polysaccharides
4.
Article in English | IMSEAR | ID: sea-25798

ABSTRACT

Though Chromobacterium violaceum is a common inhabitant of soil and water in tropical and sub-tropical regions, human infections are rare but when they do occur result in high mortality. Since the first case from Malaysia in 1927, about 150 cases have been reported in world literature. Till date 6 cases have been reported from southern and eastern parts of India. We report here a case of C. violaceum septicaemia, probably the first case from north India. The patient, a 6 and a half year old boy was admitted with high fever. The patient had anaemia, neutrophilic leucocytosis and bilateral chest infiltrates. Routine and bacteriological investigations were carried out to establish the aetiological diagnosis. C. violaceum was isolated in pure culture from blood and pus. The patient was successfully treated with ciprofloxacin and amikacin. This is probably the first documented case report of C. violaceum infection from north India and the only Indian case with septicaemia which survived.


Subject(s)
Adult , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Child , Child, Preschool , Chromobacterium/pathogenicity , Ciprofloxacin/therapeutic use , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Male , Sepsis/drug therapy
5.
Genet. mol. res. (Online) ; 3(1): 148-161, Mar. 2004.
Article in English | LILACS | ID: lil-417577

ABSTRACT

Chromobacterium violaceum is a versatile, Gram-negative beta-protebacterium that grows in a variety of ecosystems in tropical and subtropical areas, such as the water and borders of the Negro River, in the Amazon region of Brazil. Although it is a saprophyte and is generally considered non-pathogenic, sporadic cases of human infection have been described, mainly in young children and in immunodeficient individuals. Although rare, infections with C. violaceum are characterized by rapid dissemination and high mortality. With the complete genome sequence of C. violaceum now available, a detailed description of the molecular arsenal required for this bacterium's remarkable versatility has been revealed. Most importantly, a more detailed picture of its biotechnological properties, including the characteristic violacein pigment, has emerged. The complete genome sequence also enabled us to make a thorough examination of the repertoire of genes encoding probable virulence factors, which determine the potential for pathogenesis. We described a number of genes involved in infectious processes, such as host cell adhesion, [quot ]contact-dependent secretion[quot ] of factors that promote cell invasion, as well as other virulence factors, such as cytolytic proteins. We also described genes involved with the synthesis of lipopolysaccharides and proteoglycan, known to elicit the synthesis of pro-inflammatory cytokines and involved in the detoxification process, which may contribute to the evasion of the bacteria from the host immune response


Subject(s)
Chromobacterium/genetics , Virulence Factors/genetics , Genome, Bacterial , Lipopolysaccharides/biosynthesis , Bacterial Adhesion/genetics , Chromobacterium/pathogenicity , Colicins/biosynthesis , Colicins/genetics , Hemolysin Proteins/biosynthesis , Hemolysin Proteins/genetics , Indoles , Virulence/genetics
SELECTION OF CITATIONS
SEARCH DETAIL